SamjinPharm’s ‘Research for Targeted Therapy for Metastatic Breast Cancer’ selected for government’s support

Published: 2017-05-24 13:32:56

Updated: 2017-05-24 13:32:56

SamjinPharm(CEO Sung-Woo Lee) Central Laboratory announced its ‘Development Project of Targeted Therapy for Metastatic Breast Cancer Patients’ was selected as part of the ‘New Drug Development Pipeline Management Project’ organized by the Ministry of Science, ICT and Future Planning.

The development project for targeted therapy for metastatic breast cancer has been conducted by SamjinPharm and...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.